↓ Skip to main content

Cochrane Database of Systematic Reviews

Serenoa repens for benign prostatic hyperplasia

Overview of attention for article published in Cochrane database of systematic reviews, December 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Citations

dimensions_citation
98 Dimensions

Readers on

mendeley
277 Mendeley
Title
Serenoa repens for benign prostatic hyperplasia
Published in
Cochrane database of systematic reviews, December 2012
DOI 10.1002/14651858.cd001423.pub3
Pubmed ID
Authors

James Tacklind, Roderick MacDonald, Indy Rutks, Judith U Stanke, Timothy J Wilt

Abstract

Benign prostatic hyperplasia (BPH) is a nonmalignant enlargement of the prostate, which can lead to obstructive and irritative lower urinary tract symptoms (LUTS). The pharmacologic use of plants and herbs (phytotherapy) for the treatment of LUTS associated with BPH is common. The extract of the berry of the American saw palmetto, or dwarf palm plant, Serenoa repens (SR), which is also known by its botanical name of Sabal serrulatum, is one of several phytotherapeutic agents available for the treatment of BPH.

Twitter Demographics

The data shown below were collected from the profiles of 19 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 277 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 2 <1%
Italy 2 <1%
Australia 1 <1%
Brazil 1 <1%
Belgium 1 <1%
Unknown 270 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 54 19%
Student > Bachelor 49 18%
Researcher 30 11%
Other 22 8%
Student > Postgraduate 21 8%
Other 67 24%
Unknown 34 12%
Readers by discipline Count As %
Medicine and Dentistry 138 50%
Nursing and Health Professions 22 8%
Agricultural and Biological Sciences 17 6%
Pharmacology, Toxicology and Pharmaceutical Science 16 6%
Biochemistry, Genetics and Molecular Biology 10 4%
Other 33 12%
Unknown 41 15%

Attention Score in Context

This research output has an Altmetric Attention Score of 80. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 April 2021.
All research outputs
#319,638
of 17,530,453 outputs
Outputs from Cochrane database of systematic reviews
#691
of 11,711 outputs
Outputs of similar age
#3,198
of 264,201 outputs
Outputs of similar age from Cochrane database of systematic reviews
#34
of 491 outputs
Altmetric has tracked 17,530,453 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,711 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.2. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 264,201 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 491 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.